Regular Post Written by MOCC 6 September 2018 Morriss O’Bryant Compagni Cannon obtains patent for Beijing Guiqianjin Medical Science and Technology Co., Ltd. Title: USE OF ALPHA-(8-QUINOLINYLOXY) MONO-SUBSTITUTED PHTHALOCYANINE ZINC FOR TREATMENT OF PSORIASIS Patent No. 10,058,611 Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Google+ (Opens in new window) Related Issued Patents 0